Back to Authors

Pegg, Emily

0000-0001-5018-5494

Mayo Clinic

University of Manchester

Citations 1

The Intersection of Menopause and Epilepsy: A Review of Current Knowledge and Gaps
Latt, Thazin, Alkhaldi, Modhi , Puntambekar, Preeti , Sheth, Anumeha, Conner, Kelly , Ortiz‐Guerrero, Gloria , Snehal, Isha , Krishnaiengar, Suparna, Mihaylova, Temenuzhka , Moore‐Hill, Debra , Norton, Anna , Ortiz-Guerrero, Gloria , Voinescu, P. Emanuela , Smith, Kelsey M. , Zarroli, Katherine A. , Pegg, Emily , Decker, Barbara , Blank, Leah J. , Bromley, Rebecca , Cavitt, Jennifer , Norton, Anna, Bui, Esther , Vadlamudi, Lata

EMJ Neurology | August 5, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.33590/emjneurol/jpeb4231 Get It

While hormonal changes have been recognised to influence seizure control and have been studied in association with menstrual cycles and pregnancy, there is a paucity of data on the menopause transition in epilepsy. Given the known effects of sex steroid hormones on neuronal excitability, their endogenous fluctuations during perimenopause, as well as menopause hormone treatments, may alter seizure control. Epilepsy may also be associated with premature ovarian insufficiency and early menopause. This is especially important for epilepsy-related comorbidities, for which menopause can constitute a second hit, such as osteoporosis. Additional considerations for females with epilepsy across the menopause continuum include changes in antiseizure medication clearance and potential interactions with menopausal hormone therapy or other concomitant medications. This comprehensive review summarises the currently available literature on epilepsy and menopause, highlights gaps in knowledge, and underscores the need for research efforts, particularly longitudinal studies investigating the menopause transition.